معرفی
Professor John Hayball is a leading academic at the University of South Australia within the Clinical and Health Sciences school. His primary research focus lies at the intersection of biomaterials and immune response modulation, particularly examining how surface chemistry and nanotopography affect macrophage polarization, protein adsorption, and inflammatory signaling pathways.
- Key research areas: Biomaterial design, vaccine development, cervical cancer molecular mechanisms
- Current projects: Surface chemistry effects on autophagy, nano-engineered implants, SARS-CoV-2 vaccine platforms
Research Trends from his 15 most recent publications (2025-2018) show consistent exploration of:
- Surface property-immune system interactions (12 articles)
- Cervical cancer progression mechanisms (3 articles)
- Vaccine vector optimization (5 articles)
- Cytokine signaling in arthritis (4 articles)
Academic Leadership: Serves as Research Degree Supervisor, with affiliations to multiple institutes including the Experimental Therapeutics Laboratory and Sansom Institute for Health Research. Holds significant grants from ARC (DP180101254, DP220103543) and NHMRC (1194466) for biomaterial and vaccine research. Collaborates extensively with interdisciplinary teams across Australia and internationally.
